|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 47/26 | |||
| A61K 9/19 | |||
| C07K 16/18 |
| (11) | Number of the document | 3016677 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14752412.8 |
| Date of filing the European patent application | 2014-07-03 | |
| (97) | Date of publication of the European application | 2016-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/062806 |
| Date | 2014-07-03 |
| (87) | Number | WO 2015/001504 |
| Date | 2015-01-08 |
| (30) | Number | Date | Country code |
| 201361843011 P | 2013-07-04 | US | |
| 201461979886 P | 2014-04-15 | US |
| (72) |
GARIDEL, Patrick, DE
LANGER, Andreas, DE
GRUNDMAN, Michael, US
|
| (73) |
Prothena Biosciences Limited,
Adelphi Plaza Upper George`s Street D n Laoghaire, Co. Dublin, A96 T927,
IE
|
| (54) | ANTIBODY FORMULATIONS AND METHODS |
| ANTIBODY FORMULATIONS AND METHODS |